Preparing for the next pandemic

New England Journal of Medicine

Volumn 352, Issue 18, 2005, Pages 1839-1842

  Osterholm, Michael T ^a,b,c  

^a Ctr for Infect Dis Res and Plcy   (United States)

^b Natl Ctr for Food Protect/Def   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; CYTOKINE;

ADULT RESPIRATORY DISTRESS SYNDROME; CELL CULTURE; DRUG RESEARCH; ENDEMIC DISEASE; HEALTH CARE DELIVERY; HUMAN; INFLUENZA; INFLUENZA VIRUS; PANDEMIC DISEASE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SEASONAL VARIATION; SEVERE ACUTE RESPIRATORY SYNDROME; VACCINE PRODUCTION; VIRUS TRANSMISSION; ARTICLE; EPIDEMIC; HEALTH; IMMUNOLOGY; PHYSIOLOGY; PUBLIC HEALTH SERVICE; VIROLOGY;

CYTOKINES; DISEASE OUTBREAKS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PUBLIC HEALTH PRACTICE; RESPIRATORY DISTRESS SYNDROME, ADULT; WORLD HEALTH;

EID: 17944363471     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMp058068     Document Type: Review

References (5)

1. Johnson NP, Mueller J. Updating the account lobal mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med 2002;76:105-15.
2. Stöhr K. Avian influenza and pandemics - research needs and opportunities. N Engl J Med 2005;352:405-7.
3. Sandman PM, Lanard J. Pandemic influenza risk communication: the teachable moment. 2005. (Accessed April 14, 2005, at http://www.psandman.com/ col/pandemic.htm.)
4. Kobasa D, Takada A, Shinya K, et al. Enhanced virulence of influenza A viruses with haemagglutinin of the 1918 pandemic virus. Nature 2004;431:703-7.
5. Peiris JS, Yu WC, Leung CW, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004;363:617-9.